Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study.
Saved in:
| Title: | Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study. |
|---|---|
| Authors: | Dummer, R.1 (AUTHOR) reinhard.dummer@usz.ch, Guminksi, A.2,3,4 (AUTHOR), Gutzmer, R.5 (AUTHOR), Lear, J.T.6 (AUTHOR), Lewis, K.D.7 (AUTHOR), Chang, A.L.S.8 (AUTHOR), Combemale, P.9,10 (AUTHOR), Dirix, L.11 (AUTHOR), Kaatz, M.12 (AUTHOR), Kudchadkar, R.13 (AUTHOR), Loquai, C.14 (AUTHOR), Plummer, R.15 (AUTHOR), Schulze, H.‐J.16 (AUTHOR), Stratigos, A.J.17 (AUTHOR), Trefzer, U.18 (AUTHOR), Squittieri, N.19 (AUTHOR), Migden, M.R.20 (AUTHOR) |
| Source: | British Journal of Dermatology. Jun2020, Vol. 182 Issue 6, p1369-1378. 10p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070963 |
|---|---|
| DOI: | 10.1111/bjd.18552 |
